article January 16, 2023

ACRP responds to FDA draft guidance on diversity in clinical trials

We’re honored to share the Association of Clinical Research Professionals (ACRP)’s Diversity Advisory Committee (DAC) was recently published in Update – the Food and Drug Law Institute (FDLI)’s quarterly magazine – after responding to the FDA diversity draft guidance in April 2022. Javara’s own Ashley Moultrie serves on the DAC and was a contributor.

Read the full article here! Shared with the permission of FDLI.